Among the various molecular targets, glypican-3 (GPC3), a membrane-bound heparan sulfate proteoglycan expressed at negligible levels in normal liver but markedly upregulated in HCC, has attracted significant attention [203]. Here, GPC3 is linked to hepatocellular carcinoma.